• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: UNITED STATES ENDOSCOPY GROUP, INC. INFINITY SAMPLE DEVICE; INFINITY SAMPLING DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

UNITED STATES ENDOSCOPY GROUP, INC. INFINITY SAMPLE DEVICE; INFINITY SAMPLING DEVICE Back to Search Results
Model Number 00711652
Device Problem Insufficient Information (3190)
Patient Problem Unspecified Infection (1930)
Event Type  Injury  
Event Description
On (b)(6) 2014, a us endoscopy product specialist received a complaint from customer (nurse manager, (b)(6)), concerning a physician's discontinued use of the infinity sampling device (00711652).The nurse manager conveyed the physician had stopped using the device because it may have led to pancreatitis in one of his patients, after endoscopic retrograde cholangiopancreatography (ercp).The device lot number and the date of the event were unknown.In follow up communication, the patient condition was described as a mild case of pancreatitis.The physician described a very tight stricture and stated he probably shouldn't have used the brush in that particular case.He stated that he will continue to use it in other cases.The physician did not report any device malfunction when operating the device.
 
Manufacturer Narrative
The device was not returned for evaluation.Consequently, there is no further investigation into the condition of the device.Post-ercp pancreatitis is a known complication of ercp.It can be triggered by multiple causative factors, including the mechanical, thermal, chemical and hydrostatic factors which are common to ercp.Clinical literature identifies pancreatitis is the most frequent complication of ercp (reference f.Donnellan and m.Byrne, "prevention of post-ercp pancreatitis." gastroenterology research and practice, vol.2012, article id 796751).The instructions for use (ifu) includes: contraindications include those specific to any endoscopic procedure, as well as those specific to ercp, and any techniques associated with ductal brush cytology.A review of complaint history (2011 - current) finds no other complaints reported for post-ercp pancreatitis with use of the infinity sampling device.Approximately (b)(4) devices were distributed during that same period.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFINITY SAMPLE DEVICE
Type of Device
INFINITY SAMPLING DEVICE
Manufacturer (Section D)
UNITED STATES ENDOSCOPY GROUP, INC.
5976 heisley road
mentor OH 44060
Manufacturer Contact
michael oleksa
5976 heisley road
mentor, OH 44060
4403586263
MDR Report Key3934655
MDR Text Key17263974
Report Number1528319-2014-00008
Device Sequence Number1
Product Code FDX
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 06/24/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number00711652
Device Catalogue Number00711652
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 06/03/2014
Initial Date FDA Received06/25/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-